Orgametril (Lynestrenol)

Lynestrenol, the active ingredient in Orgametril, is a progestogen presented as a tablet for oral use. It is used as a hormonal contraceptive to prevent pregnancy in women of reproductive age.

GNH USA supplies Orgametril as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orgametril (lynestrenol) is a progestogenic hormonal contraceptive used to prevent pregnancy.

- Contraception: Prevents ovulation and creates cervical mucus changes to reduce the chance of fertilisation.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: discomfort or swelling of the breasts. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional lability. - Irregular bleeding: spotting or breakthrough bleeding.

Serious or Rare Side Effects: - Thromboembolic events: deep‑vein thrombosis or pulmonary embolism. - Hepatic dysfunction: jaundice or abnormal liver enzymes. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Depression: new or worsening depressive symptoms. - Visual disturbances: blurred vision or ocular pain. - Persistent hypertension: elevated blood pressure not controlled by medication.

Before prescribing Orgametril, clinicians should evaluate individual risk factors and counsel patients on safe use.

- Assess thromboembolism risk: avoid in women with a history of clotting disorders. - Avoid in estrogen‑dependent tumors: contraindicated for known breast or endometrial cancer. - Monitor blood pressure: watch for hypertension during therapy. - Evaluate liver function: use with caution in hepatic impairment. - Store at below 25°C: keep in the original pack, protect from moisture.

Lynestrenol may interact with other medicines that alter its metabolism or efficacy.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): reduce contraceptive effectiveness. - Rifampicin: strong inducer that may lower plasma levels. - Certain antiretrovirals (e.g., efavirenz): decrease hormonal activity.

Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics (e.g., tetracycline): possible modest reduction in effect. - Antifungals (e.g., fluconazole): may increase plasma concentration. - St. John’s wort: herbal inducer that could lower efficacy.